Your search for comorbidities returned 105 results

Researchers sought to determine if risk factors for cardiovascular disease and complications changed during different phases of the COVID-19 pandemic.

Researchers evaluated immune responses to viral vectored-, mRNA-, and protein-based COVID-19 vaccine platforms across homologous and heterologous priming combinations.

Odds of mortality or discharge to hospice reduced for those receiving supplemental oxygen or mechanical ventilation and/or ECMO

What was the real-world effect of nirmatrelvir-ritonavir treatment in outpatients with early COVID-19 infection during the Omicron-predominant period of the pandemic?

A study was conducted to determine cardiovascular outcomes in patients hospitalized with myocarditis secondary to COVID-19 infection.

Researchers evaluated risk factors associated with persistent COVID-19 symptoms at 28 and 90 days following infection onset.

Researchers sought to determine the prevalence of endothelial dysfunction in patients with CVD and history of COVID-19 infection.

The risks and predictors of COVID-19 hospitalization and mortality were studied among patients with early inflammatory arthritis.

Researchers conducted a study to assess the long-term effects of COVID-19 infection in comparison with other common respiratory viral infections.

Researchers evaluated the efficacy and safety of favipiravir among patients hospitalized with COVID-19.